Date & Time: 20 October 2022, 15:00 – 19:00 (registration from 14:30) Venue: Delegation of the European Union to Japan, Europa House, 4-6-28 Minami-Azabu, Minato-ku, Tokyo, 106-0047 Organized by: EU-Japan... read more →
News
EU-Japan Technology Transfer Helpdesk / Category: News
WEBINAR: Realizing Digital Societies with Comprehensive Data Infrastructure, and Workforce Education
Join us on Thursday, September 8th to learn the latest efforts in developing IT professionals, how data infrastracture, interoperability and standardization can help bridge the skill gaps with speakers from... read more →
A plant breeding and biotechnology company working on innovative genetic solutions for agriculture is seeking technical solutions to allow the cultivation and crossing of soybeans within a 60-day lifecycle (from... read more →
Grünenthal is a global leader in pain management, seeking new chemical entities and novel targets with first‐in‐class potential for the treatment of pain in humans. Grünenthal is also interested in... read more →
A global life sciences measurement and tools company with cutting-edge capabilities in genomic analysis and quality assurance wishes to identify novel approaches for scalable synthesis of oligonucleotides.
Healx, an AI-powered, patient-inspired, biotech company, is seeking rare disease therapeutic opportunities from academic, patient groups or (early-stage) biotechs. Healx, along with their partners, aim to quickly turn research into... read more →
Chiesi Global Rare Diseases is seeking research proposals for new technologies from academic medical centres, universities, and research institutions globally. Their objective is to award funds to validate early‐stage projects... read more →
A global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to identify research related to the generation of T cells, both alpha... read more →
BioMarin Pharmaceutical Inc. is a world leader in developing and commercialising first- or best-in-class therapies for rare genetic diseases. BioMarin Pharmaceutical Inc. is looking for expertise in the pathology and... read more →
BioMarin Pharmaceutical Inc. is a world leader in developing and commercialising first- or best-in-class therapies for rare genetic diseases. C‐type natriuretic peptide (CNP) is a growth factor with receptors expressed... read more →
